Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Merck presents clinical data on COX-2 inhibitor at FASEB 98

April 28, 1998

New findings support the hypothesis that fetal cells are involved in scleroderma

April 28, 1998

Dupuytren's disease treatment shows promise in early clinical trials

April 28, 1998

Chemokine receptor antagonists developed at Banyu

April 24, 1998

Doxycycline to be evaluated for the treatment of osteoarthritis

April 23, 1998

PKC inhibitors for inflammatory, immune, allergic and other disorders described by Otsuka

April 22, 1998

Pharmacokinetics and pharmacodynamics of IDEC-151 reported at European rhematology meeting

April 22, 1998

New antirheumatic agent shown effective in long-term patient studies

April 22, 1998

Shire to market Fidia's new osteoarthritis treatment

April 21, 1998

Unexpected results from a study of gene therapy for rheumatoid arthritis

April 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026